Pre-Implantation Methylation Screening (PIMS)
A pioneering technology to greatly increase the live birth rate and reduce the birth defects in ART practice, helping families relief from mental struggling and economic burden.
Preimplantation DNA Methylation Screening Kit (PIMS Kit)
Worldwide pioneering technology with 8 years of ingenious research and development
Three platforms based on epigenetic technology + big data
About Us
Providing integrated solution for reproduction
Making infertility and birth defects history
Guangzhou Nvwa Life Technology Co., Ltd. is a world-leading innovative company with genome epigenetics research and medical transformation platform. On two major technology platforms (the technology platform of whole-genome library preparation of trace cells and the database platform of human epigenetics), Nvwa aims for longitudinal and in-depth development and promotion of products in the epigenetic field and market, which indicate the product pathway from assisted reproductive tests, to obstetrical as well as neonatal epigenetic disease tests, and then from epigenetic diagnosis to epigenetic editing treatment.
World-class R & D team
Innovative technology in its first
BSL-2 Medical Laboratory
News Center
-
On August 23rd, the winners of the HICOOL 2024 Global Entrepreneurship Competition were announced at the HICOOL 2024 Global Entrepreneurs Summit. The "Pioneering Application of Epigenetics in Reproductive Medicine" project by Nuwa Life won the third prize! In this grand gathering of global wisdom, we competed with 7,406 projects and 9,700 top innovators from 124 countries and regions, showcasing our strength and innovative spirit. Receiving recognition on such an international stage is a high affirmation of our potential for future development, and we are deeply honored. We thank every partner who supports us and every team member for their hard work and relentless pursuit. It is your creativity and efforts that have made this moment possible. This honor belongs to each of us and is the result of our joint struggle. We will continue to uphold the spirit ... -
In December 2021, Guangzhou Nvwa Life Technology Co., Ltd. signed strategic cooperation agreements with CITIC Xiangya Genetics and Reproductive Specialist Hospital, the University of Hong Kong Shenzhen Hospital, and Shenyang Shengjing Hospital, aiming to cooperate in national scientific programs, research and development, and clinical trials. -
The 2021 Huangpu District Leading Talent Competition was officially launched on October 25. High-level technology talents from 79 companies in the district competed for the award. After rounds of fierce competition, the founder of Guangzhou Nvwa Life Technology Co., Ltd. was selected as one of the awardees in Huangpu District, Guangzhou.
